Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

147 records in Main database · 128 strong · 139 status checkedPage 1 of 3

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	Otarmeni by Regeneron	Regeneron Pharmaceuticals	Therapeutic	-	Gene Therapy	Approved	Approved	Details checkedStrong evidence	regulatory · Priority 1	99%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	PEDMARK by Fennec Pharmaceuticals	Fennec Pharmaceuticals	Therapeutic	-	Small Molecule	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	98%	PediatricCisplatin Ototoxicity	Cisplatin-Induced Hearing LossHearing Loss
Add	Apple AirPods Pro Hearing Health Features	Apple	Software/Neurotech	OTC Hearing Aids	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	97%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+1
Add	AK-OTOF by Eli Lilly and Akouos	Eli Lilly and Company	Therapeutic	-	Gene Therapy	Phase 2	Active	Details checkedStrong evidence	trial · Priority 1	95%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	Nuance Audio Hearing Aid Software	EssilorLuxottica	Software/Neurotech	OTC Hearing Aids	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	95%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear Nucleus Nexa System	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	94%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	SENS-401 (Arazasetron) by Sensorion	Sensorion	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 1	94%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	SENS-501 by Sensorion	Sensorion	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	94%	PediatricCongenital+5	Hearing LossSensorineural Hearing Loss+3
Add	Envoy Medical Acclaim Cochlear Implant	Envoy Medical	Device	Cochlear Implants	Cochlear/Auditory Implant	Phase 2/3	Active	Details checkedStrong evidence	trial · Priority 1	93%	AdultPost-Lingual+1	Hearing LossSensorineural Hearing Loss
Add	MED-EL SYNCHRONY Cochlear Implant System	MED-EL	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	93%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	Cochlear Nucleus Profile Plus CI600 Series Implants	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	92%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	Phonak Audéo Sphere Infinio	Phonak	Device	AI Audio	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	92%	AdultAge-Related+2	Hearing LossSensorineural Hearing Loss+1
Add	Rincell-1 by Rinri Therapeutics	Rinri Therapeutics	Therapeutic	-	Cell Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	92%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	AC102 by AudioCure Pharma	AudioCure Pharma	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	trial · Priority 1	91%	AdultSudden / SSNHL+1	Hearing LossSensorineural Hearing Loss+2
Add	Advanced Bionics HiRes Ultra 3D and Naída CI Marvel Platform	Advanced Bionics	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	91%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	HIMSA Noah ES and Noah System	HIMSA	Software/Neurotech	Fitting Software	Fitting Software/Workflow	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	91%	AdultPediatric+3	Hearing LossSensorineural Hearing Loss
Add	ReSound Vivia	GN ReSound	Device	AI Audio	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	90%	AdultAge-Related+2	Hearing LossSensorineural Hearing Loss+1
Add	SPI-1005 by Sound Pharmaceuticals	Sound Pharmaceuticals	Therapeutic	-	Small Molecule	Phase 3	Active	Details checkedStrong evidence	trial · Priority 1	90%	AdultNoise-Induced+2	Hearing LossSensorineural Hearing Loss+3
Add	MED-EL SYNCHRONY ABI	MED-EL	Device	Auditory BCI / Neurotech	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	86%	Profound	Hearing Loss
Add	Envoy Medical Esteem Fully Implanted Hearing System	Envoy Medical	Device	Bone Conduction & Middle Ear	Active Middle Ear Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	97%	AdultModerate to Severe+3	Hearing LossSensorineural Hearing Loss
Add	Cochlear Osia System	Cochlear	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	96%	PediatricAdult+2	Hearing LossConductive Hearing Loss+2
Add	Cochlear Nucleus ABI541 Brainstem Implant	Cochlear	Device	Auditory BCI / Neurotech	BCI/Neurotech	Approved	Approved	Details checkedStrong evidence	regulatory · Priority 2	95%	AdultPost-Lingual+1	Hearing LossAuditory Neuropathy
Add	MED-EL VIBRANT SOUNDBRIDGE	MED-EL	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	95%	AdultUnilateral+2	Hearing LossSensorineural Hearing Loss+2
Add	ACOU085 by Acousia Therapeutics	Acousia Therapeutics GmbH	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 2	93%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	CIL001 (Paliroden) by Cilcare	Cilcare SAS	Therapeutic	-	Small Molecule	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultDiabetes+2	Hearing LossSensorineural Hearing Loss+2
Add	Cochlear Baha 7 Sound Processor	Cochlear	Device	Bone Conduction & Middle Ear	Bone Conduction / Middle-Ear Device	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	92%	AdultPediatric+4	Hearing LossConductive Hearing Loss+2
Add	Cochlear Baha System	Cochlear	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	92%	PediatricAdult+4	Hearing LossConductive Hearing Loss+2
Add	MED-EL ADHEAR System	MED-EL	Device	Bone Conduction & Middle Ear	Bone Conduction / Middle-Ear Device	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	92%	AdultPediatric+2	Hearing LossConductive Hearing Loss+2
Add	NS101 by Neuracle Science	Neuracle Science Co., Ltd.	Therapeutic	-	Biologic	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	Earlens Contact Hearing Solution	Earlens Corporation	Device	Bone Conduction & Middle Ear	Bone Conduction / Middle-Ear Device	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	91%	AdultClinical Audiology+2	Hearing LossSensorineural Hearing Loss+2
Add	GeoAxon Kuduwave Pro	GeoAxon	Diagnostic	Diagnostics	Diagnostic	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultPediatric+3	Hearing LossSensorineural Hearing Loss
Add	Google Sound Amplifier	Google	Software/Neurotech	AI Audio	AI Audio/Speech Accessibility Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultPediatric+4	Hearing Loss
Add	PATH MEDICAL SENTIERO ADVANCED	PATH MEDICAL	Diagnostic	Diagnostics	Diagnostic	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	91%	AdultPediatric+4	Hearing LossAuditory Neuropathy+1
Add	Phonak Audéo Infinio Ultra R	Phonak	Device	Prescription Hearing Aids	Prescription Hearing Aid	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultPrescription Hearing Aid+4	Hearing LossSensorineural Hearing Loss+1
Add	ReSound Nexia	GN ReSound	Device	Prescription Hearing Aids	Prescription Hearing Aid	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultPrescription Hearing Aid+5	Hearing LossSensorineural Hearing Loss+1
Add	Signia Integrated Xperience	Signia	Device	AI Audio	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultAge-Related+2	Hearing LossSensorineural Hearing Loss+1
Add	Signia Silk Charge&Go IX	Signia	Device	Prescription Hearing Aids	Prescription Hearing Aid	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	91%	AdultPrescription Hearing Aid+4	Hearing LossSensorineural Hearing Loss
Add	AK-antiVEGF by Eli Lilly and Akouos	Eli Lilly and Company	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	90%	AdultUnilateral+2	Vestibular SchwannomaHearing Loss
Add	Apple Live Captions	Apple	Software/Neurotech	AI Audio	AI Audio/Speech Accessibility Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+4	Hearing Loss
Add	Audioscan Verifit2	Audioscan	Diagnostic	Diagnostics	Diagnostic/Fitting Verification	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+3	Hearing LossSensorineural Hearing Loss
Add	Ava Live Captions	Ava	Software/Neurotech	AI Audio	AI Audio/Speech Accessibility Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+5	Hearing Loss
Add	ClearCaptions Phone and Mobile Captioning Service	ClearCaptions	Software/Neurotech	AI Audio	AI Audio/Captioning	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultOlder Adult+3	Hearing Loss
Add	Cochlear Custom Sound Pro Fitting Software	Cochlear	Software/Neurotech	Fitting Software	Cochlear Implant Programming Software/Workflow	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+1	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear Nucleus 8 Sound Processor	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear Nucleus Kanso 3 Sound Processor	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	Interacoustics Affinity Compact	Interacoustics	Diagnostic	Diagnostics	Diagnostic/Fitting Verification	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+3	Hearing LossSensorineural Hearing Loss
Add	Microsoft Windows Live Captions	Microsoft	Software/Neurotech	AI Audio	AI Audio/Speech Accessibility Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+4	Hearing LossCommunication Impairment
Add	Natus AURICAL FreeFit	Natus	Diagnostic	Diagnostics	Diagnostic/Fitting Verification	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPediatric+3	Hearing LossSensorineural Hearing Loss
Add	Phonak Lyric	Phonak	Device	Prescription Hearing Aids	Hearing Aid/Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultAge-Related+2	Hearing LossSensorineural Hearing Loss+1
Add	Phonak Naída Lumity Power Hearing Aids	Phonak	Device	Prescription Hearing Aids	Prescription Hearing Aid	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	AdultPrescription Hearing Aid+5	Hearing LossSensorineural Hearing Loss+1

Otarmeni by Regeneron

Regeneron Pharmaceuticals · Gene Therapy · Approved

ApprovedTherapeuticStronger sources

Evidence

regulatory

Confidence

99%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricAdultCongenitalGenetic

Details

PEDMARK by Fennec Pharmaceuticals

Fennec Pharmaceuticals · Small Molecule · Marketed

MarketedTherapeuticStronger sources

Evidence

regulatory

Confidence

98%

Indications

Cisplatin-Induced Hearing LossHearing Loss

Population

PediatricCisplatin Ototoxicity

Details

Apple AirPods Pro Hearing Health Features

Apple · Hearing Aid/Software · Marketed

MarketedSoftware/NeurotechOTC Hearing AidsStronger sources

Evidence

regulatory

Confidence

97%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-Lingual

Details

AK-OTOF by Eli Lilly and Akouos

Eli Lilly and Company · Gene Therapy · Phase 2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricAdultCongenitalGenetic

Details

Nuance Audio Hearing Aid Software

EssilorLuxottica · Hearing Aid/Software · Marketed

MarketedSoftware/NeurotechOTC Hearing AidsStronger sources

Evidence

regulatory

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-Lingual

Details

Cochlear Nucleus Nexa System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

94%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

SENS-401 (Arazasetron) by Sensorion

Sensorion · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

company

Confidence

94%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCisplatin-Induced Hearing Loss

Population

AdultSudden / SSNHLCisplatin OtotoxicityCochlear Implant

Details

SENS-501 by Sensorion

Sensorion · Gene Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

94%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricCongenitalGeneticOTOF / DFNB9

Details

Envoy Medical Acclaim Cochlear Implant

Envoy Medical · Cochlear/Auditory Implant · Phase 2/3

ActiveDeviceCochlear ImplantsStronger sources

Evidence

trial

Confidence

93%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPost-LingualProfound

Details

MED-EL SYNCHRONY Cochlear Implant System

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

regulatory

Confidence

93%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

Cochlear Nucleus Profile Plus CI600 Series Implants

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantImplantable Device

Details

Phonak Audéo Sphere Infinio

Phonak · Hearing Aid/Software · Marketed

MarketedDeviceAI AudioStronger sources

Evidence

company

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-LingualModerate to Severe

Details

Rincell-1 by Rinri Therapeutics

Rinri Therapeutics · Cell Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy

Population

AdultAge-RelatedAuditory Neuropathy

Details

AC102 by AudioCure Pharma

AudioCure Pharma · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

91%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossTinnitus

Population

AdultSudden / SSNHLTinnitus

Details

Advanced Bionics HiRes Ultra 3D and Naída CI Marvel Platform

Advanced Bionics · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

HIMSA Noah ES and Noah System

HIMSA · Fitting Software/Workflow · Marketed

MarketedSoftware/NeurotechFitting SoftwareStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricClinical AudiologyFitting Workflow

Details

ReSound Vivia

GN ReSound · Hearing Aid/Software · Marketed

MarketedDeviceAI AudioStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-LingualModerate to Severe

Details

SPI-1005 by Sound Pharmaceuticals

Sound Pharmaceuticals · Small Molecule · Phase 3

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossTinnitus

Population

AdultNoise-InducedTinnitusCisplatin Ototoxicity

Details

MED-EL SYNCHRONY ABI

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceAuditory BCI / NeurotechStronger sources

Evidence

company

Confidence

86%

Indications

Hearing Loss

Population

Profound

Details

Envoy Medical Esteem Fully Implanted Hearing System

Envoy Medical · Active Middle Ear Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

97%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultModerate to SeverePost-LingualActive Middle Ear Implant

Details

Cochlear Osia System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

96%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss

Population

PediatricAdultUnilateralBilateral

Details

Cochlear Nucleus ABI541 Brainstem Implant

Cochlear · BCI/Neurotech · Approved

ApprovedDeviceAuditory BCI / NeurotechStronger sources

Evidence

regulatory

Confidence

95%

Indications

Hearing LossAuditory Neuropathy

Population

AdultPost-LingualProfound

Details

MED-EL VIBRANT SOUNDBRIDGE

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossConductive Hearing LossMixed Hearing Loss

Population

AdultUnilateralBilateralModerate to Severe

Details

ACOU085 by Acousia Therapeutics

Acousia Therapeutics GmbH · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

company

Confidence

93%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossCisplatin-Induced Hearing Loss

Population

AdultAge-RelatedCisplatin Ototoxicity

Details

CIL001 (Paliroden) by Cilcare

Cilcare SAS · Small Molecule · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy

Population

AdultDiabetesCochlear SynaptopathyHidden Hearing Loss

Details

Cochlear Baha 7 Sound Processor

Cochlear · Bone Conduction / Middle-Ear Device · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

92%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSingle-Sided Deafness

Population

AdultPediatricBone Conduction ProcessorSingle Sided Deafness

Details

Cochlear Baha System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

company

Confidence

92%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss

Population

PediatricAdultUnilateralBilateral

Details

MED-EL ADHEAR System

MED-EL · Bone Conduction / Middle-Ear Device · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

92%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSingle-Sided Deafness

Population

AdultPediatricNon Surgical Bone ConductionSingle Sided Deafness

Details

NS101 by Neuracle Science

Neuracle Science Co., Ltd. · Biologic · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCochlear Synaptopathy

Population

AdultSudden / SSNHLSensorineuralSalvage Therapy

Details

Earlens Contact Hearing Solution

Earlens Corporation · Bone Conduction / Middle-Ear Device · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

91%

Indications

Hearing LossSensorineural Hearing LossConductive Hearing LossMixed Hearing Loss

Population

AdultClinical AudiologyMiddle Ear AssessmentTympanic Contact Device

Details

GeoAxon Kuduwave Pro

GeoAxon · Diagnostic · Marketed

MarketedDiagnosticDiagnosticsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricClinical AudiologyPortable Diagnostics

Details

Google Sound Amplifier

Google · AI Audio/Speech Accessibility Software · Marketed

MarketedSoftware/NeurotechAI AudioStronger sources

Evidence

company

Confidence

91%

Indications

Hearing Loss

Population

AdultPediatricDeaf / Hard of HearingSpeech Enhancement

Details

PATH MEDICAL SENTIERO ADVANCED

PATH MEDICAL · Diagnostic · Marketed

MarketedDiagnosticDiagnosticsStronger sources

Evidence

regulatory

Confidence

91%

Indications

Hearing LossAuditory NeuropathyVestibular Disorders

Population

AdultPediatricCongenitalClinical Audiology

Details

Phonak Audéo Infinio Ultra R

Phonak · Prescription Hearing Aid · Marketed

MarketedDevicePrescription Hearing AidsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing LossSingle-Sided Deafness

Population

AdultPrescription Hearing AidReceiver In CanalRechargeable

Details

ReSound Nexia

GN ReSound · Prescription Hearing Aid · Marketed

MarketedDevicePrescription Hearing AidsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing LossSingle-Sided Deafness

Population

AdultPrescription Hearing AidReceiver In CanalBehind The Ear

Details

Signia Integrated Xperience

Signia · Hearing Aid/Software · Marketed

MarketedDeviceAI AudioStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-LingualModerate to Severe

Details

Signia Silk Charge&Go IX

Signia · Prescription Hearing Aid · Marketed

MarketedDevicePrescription Hearing AidsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPrescription Hearing AidCompletely In CanalInstant Fit

Details

AK-antiVEGF by Eli Lilly and Akouos

Eli Lilly and Company · Gene Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

90%

Indications

Vestibular SchwannomaHearing Loss

Population

AdultUnilateralVestibular SchwannomaHearing Adjacent

Details

Apple Live Captions

Apple · AI Audio/Speech Accessibility Software · Marketed

MarketedSoftware/NeurotechAI AudioStronger sources

Evidence

company

Confidence

90%

Indications

Hearing Loss

Population

AdultPediatricDeaf / Hard of HearingCaptioning

Details

Audioscan Verifit2

Audioscan · Diagnostic/Fitting Verification · Marketed

MarketedDiagnosticDiagnosticsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricClinical AudiologyFitting Verification

Details

Ava Live Captions

Ava · AI Audio/Speech Accessibility Software · Marketed

MarketedSoftware/NeurotechAI AudioStronger sources

Evidence

company

Confidence

90%

Indications

Hearing Loss

Population

AdultPediatricDeaf / Hard of HearingCaptioning

Details

ClearCaptions Phone and Mobile Captioning Service

ClearCaptions · AI Audio/Captioning · Marketed

MarketedSoftware/NeurotechAI AudioStronger sources

Evidence

company

Confidence

90%

Indications

Hearing Loss

Population

AdultOlder AdultDeaf / Hard of HearingCommunication Access

Details

Cochlear Custom Sound Pro Fitting Software

Cochlear · Cochlear Implant Programming Software/Workflow · Marketed

MarketedSoftware/NeurotechFitting SoftwareStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant Programming

Details

Cochlear Nucleus 8 Sound Processor

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant ProgrammingProfound

Details

Cochlear Nucleus Kanso 3 Sound Processor

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantPost Implant Programming

Details

Interacoustics Affinity Compact

Interacoustics · Diagnostic/Fitting Verification · Marketed

MarketedDiagnosticDiagnosticsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricClinical AudiologyFitting Verification

Details

Microsoft Windows Live Captions

Microsoft · AI Audio/Speech Accessibility Software · Marketed

MarketedSoftware/NeurotechAI AudioStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossCommunication Impairment

Population

AdultPediatricDeaf / Hard of HearingCaptioning

Details

Natus AURICAL FreeFit

Natus · Diagnostic/Fitting Verification · Marketed

MarketedDiagnosticDiagnosticsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricClinical AudiologyFitting Verification

Details

Phonak Lyric

Phonak · Hearing Aid/Software · Marketed

MarketedDevicePrescription Hearing AidsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing Loss

Population

AdultAge-RelatedPost-LingualModerate to Severe

Details

Phonak Naída Lumity Power Hearing Aids

Phonak · Prescription Hearing Aid · Marketed

MarketedDevicePrescription Hearing AidsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossMixed Hearing Loss

Population

AdultPrescription Hearing AidBehind The EarPower Hearing Aid

Details